Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3356 |
|
| Actual shortage: | 218 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
62 (26%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-MIRTAZAPINE | 45MG | TABLET | Resolved | 2017-06-08 | 2017-08-08 | 12358 |
| APO-MIRTAZAPINE | 30MG | TABLET | Resolved | 2017-07-11 | 2017-10-17 | 15370 |
| APO-MIRTAZAPINE | 15MG | TABLET | Resolved | 2017-08-14 | 2017-10-03 | 19226 |
| APO-MIRTAZAPINE | 30MG | TABLET | Resolved | 2023-11-17 | 2023-12-01 | 210662 |
| APO-MIRTAZAPINE | 45MG | TABLET | Resolved | 2023-12-08 | 2023-12-15 | 212922 |
| APO-MIRTAZAPINE | 15MG | TABLET | Resolved | 2022-03-18 | 2022-06-03 | 156996 |
| APO-MIRTAZAPINE | 30MG | TABLET | Resolved | 2022-04-29 | 2022-06-03 | 159716 |
| APO-MIRTAZAPINE | 15MG | TABLET | Resolved | 2022-06-27 | 2022-08-12 | 163453 |
| APO-MIRTAZAPINE | 30MG | TABLET | Resolved | 2022-07-15 | 2022-08-12 | 164741 |
| APO-MIRTAZAPINE | 30MG | TABLET | Resolved | 2022-12-09 | 2023-01-06 | 177603 |
| APO-MIRTAZAPINE | 30MG | TABLET | Resolved | 2019-01-09 | 2019-02-01 | 71676 |
| APO-MIRTAZAPINE | 30MG | TABLET | Resolved | 2019-03-05 | 2019-04-05 | 77893 |
| APO-MIRTAZAPINE | 15MG | TABLET | Resolved | 2022-12-16 | 2023-01-06 | 178757 |
| APO-MIRTAZAPINE | 15MG | TABLET | Resolved | 2023-02-16 | 2023-03-16 | 185013 |
| APO-MIRTAZAPINE | 30MG | TABLET | Resolved | 2023-04-14 | 2023-08-04 | 189644 |
| APO-MIRTAZAPINE | 30MG | TABLET | Resolved | 2018-05-23 | 2018-08-18 | 50156 |
| APO-MIRTAZAPINE | 15MG | TABLET | Resolved | 2018-06-04 | 2018-09-29 | 51204 |
| APO-MODAFINIL | 100MG | TABLET | Resolved | 2024-10-24 | 2024-12-13 | 241084 |
| APO-MODAFINIL | 100MG | TABLET | Resolved | 2022-02-04 | 2022-02-22 | 154181 |
| APO-MODAFINIL | 100MG | TABLET | Resolved | 2023-08-12 | 2023-10-27 | 201707 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-02-28 | 40835 |
| APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40838 |
| APO-FUROSEMIDE | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60506 |
| APO-FUROSEMIDE | 40MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60509 |
| APO-FUROSEMIDE | 80MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4719 |
| APO GLYBURIDE TAB 2.5MG | 2.5MG | TABLET | Discontinued | 2018-09-07 | 2019-07-04 | 60515 |
| APO GLYBURIDE TAB 5MG | 5MG | TABLET | Discontinued | 2018-09-07 | 2018-12-14 | 60518 |
| APO-HYDROCHLOROTHIAZIDE | Discontinued | 2019-11-26 | 2019-11-26 | 99653 | ||
| APO-HYDROCHLOROTHIAZIDE | 50MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60521 |
| APO-IBUPROFEN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60527 |
| APO-IBUPROFEN | 300MG | TABLET | Discontinued | 2019-01-02 | 2019-01-02 | 70793 |
| APO-IBUPROFEN | 400MG | TABLET | Discontinued | 2019-01-02 | 2019-01-02 | 70799 |
| APO-IBUPROFEN | 400MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60530 |
| APO-METOPROLOL (TYPE L) | 50MG | TABLET | Discontinued | 2018-09-07 | 2019-02-02 | 60634 |
| APO-METOPROLOL | 50MG | TABLET | Discontinued | 2018-09-07 | 2019-01-09 | 60631 |
| APO NAPROXEN TAB 125MG | 125MG | TABLET | Discontinued | 2018-09-08 | 2019-08-08 | 60663 |
| APO-NAPROXEN | 250MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4734 |
| APO-OXAZEPAM | 10MG | TABLET | Discontinued | 2018-09-08 | 2019-08-30 | 60675 |
| APO-OXAZEPAM | 15MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60678 |
| APO-OXAZEPAM | 30MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60681 |